EPC#

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 61 Azixa 59 TELCYTA 58 Perifosine 57 AZD# 57 NGX# 57 AP# [003] 56 PXD# 55 Bortezomib 55 phase IIb 55 selective inhibitor 55 OXi# 55 Zerenex 55 TRIOLEX 55 Phase Ib 54 dose limiting toxicities 54 Phenoptin 54 ASA# 54 CYC# 54 CA4P 54 6R BH4 53 HGS ETR1 53 orally bioavailable 53 PF # [001] 53 Phase 1b trial 53 IMGN# 53 DG# [001] 53 Phase 1a 53 PS# [001] 53 elagolix 53 ADL# 53 kinase inhibitor 53 SGX# 53 phase IIa 53 Alpharadin 52 MGCD# [001] 52 potent inhibitor 52 teduglutide 52 tezampanel 52 drug conjugate 52 blinatumomab 52 pegloticase 52 antithrombotic 52 RG# [001] 52 Phase 2b study 52 BAY #-# 52 Amigal 52 INCB# [002] 52 Phase Ia 52 Debio 51 XL# [003] 51 tolerated dose MTD 51 induce apoptosis 51 hepatotoxicity 51 Phase 2a clinical 51 Phase 2a trial 51 MB# [004] 51 confirmatory Phase III 51 TG# [001] 51 Phase 2b trial 51 Preclinical studies 51 dose cohorts 51 diabetic neuropathic pain 51 humanized monoclonal antibody 50 Everolimus 50 Phase 2a 50 Phase IIb trial 50 EGFR inhibitors 50 MF# [002] 50 Phase 1b clinical 50 PEG Interferon lambda 50 daclizumab 50 anticancer agent 50 Phase IIa clinical 50 dose escalation study 50 tyrosine kinase inhibitors 50 BCX# 50 HspE7 50 receptor antagonists 50 antisense drug 50 NRTI 50 Phase III trials 50 eculizumab 49 Initiates Phase 49 Phase IIa trial 49 MOZOBIL 49 confirmatory Phase 3 49 Phase III clinical trials 49 ISIS # 49 radiolabeled 49 CRx 49 perifosine 49 PRX# 48 voreloxin 48 Phase 2b clinical 48 multiple ascending dose 48 PARP inhibitors 48 ZYBRESTAT 48 IND enabling 48 Phase 1b 48 anti angiogenic 48 ofatumumab

Back to home page